Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have phosphatidylinositol binding activity and phosphatidylinositol transfer activity. Predicted to be involved in phosphatidylinositol metabolic process. Predicted to localize to cytoplasm. Is expressed in several structures, including central nervous system; genitourinary system; liver; retina; and small intestine. Orthologous to human PITPNC1 (phosphatidylinositol transfer protein cytoplasmic 1).